Closure of the left atrial appendage using percutaneous transcatheter occlusion devices
- 6 April 2020
- journal article
- review article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (8) , 2179-2186
Abstract
Closure of the left atrial appendage (LAA) using percutaneous transcatheter occlusion devices is used for stroke prevention as an alternative for patients with a high risk and contraindications for long‐term oral anticoagulation use. In this manuscript, we will discuss the practical aspects of four among the available devices that provide percutaneous intravascular closure of the LAA: Watchman, Amulet, WaveCrest, and LAmbre.Keywords
This publication has 18 references indexed in Scilit:
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive SummaryCirculation, 2014
- Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2013
- The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial FibrillationJACC, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialThe Lancet, 2009
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- RESECTION OF THE AURICULAR APPENDAGESAnnals of Surgery, 1950
- RESECTION OF THE LEFT AURICULAR APPENDIXJAMA, 1949